Literature DB >> 10196319

The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons.

S C Piller1, G D Ewart, D A Jans, P W Gage, G B Cox.   

Abstract

We have previously reported that the accessory protein Vpr from human immunodeficiency virus type 1 forms cation-selective ion channels in planar lipid bilayers and is able to depolarize intact cultured neurons by causing an inward sodium current, resulting in cell death. In this study, we used site-directed mutagenesis and synthetic peptides to identify the structural regions responsible for the above functions. Mutations in the N-terminal region of Vpr were found to affect channel activity, whereas this activity was not affected by mutations in the hydrophobic region of Vpr (amino acids 53 to 71). Analysis of mutants containing changes in the basic C terminus confirmed previous results that this region, although not necessary for ion channel function, was responsible for the observed rectification of wild-type Vpr currents. A peptide comprising the first 40 N-terminal amino acids of Vpr (N40) was found to be sufficient to form ion channels similar to those caused by wild-type Vpr in planar lipid bilayers. Furthermore, N40 was able to cause depolarization of the plasmalemma and cell death in cultured hippocampal neurons with a time course similar to that seen with wild-type Vpr, supporting the idea that this region is responsible for Vpr ion channel function and cytotoxic effects. Since Vpr is found in the serum and cerebrospinal fluids of AIDS patients, these results may have significance for AIDS pathology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196319      PMCID: PMC104202     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Flow cytometric analysis of membrane potential in embryonic rat spinal cord cells.

Authors:  R N Mandler; A E Schaffner; E A Novotny; G D Lange; J L Barker
Journal:  J Neurosci Methods       Date:  1988-01       Impact factor: 2.390

2.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers.

Authors:  S C Piller; G D Ewart; A Premkumar; G B Cox; P W Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

4.  HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae.

Authors:  I G Macreadie; D R Thorburn; D M Kirby; L A Castelli; N L de Rozario; A A Azad
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

Review 5.  HIV-1, Vpr and the cell cycle.

Authors:  M Emerman
Journal:  Curr Biol       Date:  1996-09-01       Impact factor: 10.834

6.  Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.

Authors:  F Re; D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

Authors:  S R Bartz; M E Rogel; M Emerman
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions.

Authors:  Y L Lu; P Spearman; L Ratner
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death.

Authors:  I G Macreadie; C K Arunagiri; D R Hewish; J F White; A A Azad
Journal:  Mol Microbiol       Date:  1996-03       Impact factor: 3.501

10.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

Authors:  P Di Marzio; S Choe; M Ebright; R Knoblauch; N R Landau
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  26 in total

1.  Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1.

Authors:  Che Ma; Francesca M Marassi; David H Jones; Suzana K Straus; Stephan Bour; Klaus Strebel; Ulrich Schubert; Myrta Oblatt-Montal; Mauricio Montal; Stanley J Opella
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Effect of extracellular HIV-1 Vpr protein in vitro.

Authors:  S C Piller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

3.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

4.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

Review 5.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

Review 6.  Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Authors:  Christopher Power; Elizabeth Hui; Pornpun Vivithanaporn; Shaona Acharjee; Maria Polyak
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-15       Impact factor: 4.147

7.  Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons.

Authors:  Emmanuelle N Sabbah; Bernard P Roques
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

8.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Authors:  Sarah Bourbigot; Hervé Beltz; Jérôme Denis; Nelly Morellet; Bernard P Roques; Yves Mély; Serge Bouaziz
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

9.  PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.

Authors:  Angélique N Godet; Julien Guergnon; Amélie Croset; Xavier Cayla; Pierre Barthélemy Falanga; Jean-Hervé Colle; Alphonse Garcia
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

10.  Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G.

Authors:  Indrapal N Singh; Robin J Goody; Celeste Dean; Nael M Ahmad; Sarah E Lutz; Pamela E Knapp; Avindra Nath; Kurt F Hauser
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.